Success Metrics

Clinical Success Rate

80.0%

Based on 8 completed trials

Completion Rate

80%(8/10)

Active Trials

1(8%)

Results Posted

0%(0 trials)

Terminated

2(15%)

Phase Distribution

Ph phase_2

15%

Ph phase_4

Ph phase_3

23%

Ph not_applicable

31%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

2(18.2%)

Phase 3Large-scale testing

3(27.3%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(8)

Terminated(3)

Other(1)

Detailed Status

Completed8

Terminated2

Recruiting1

Withdrawn1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (9.1%)

Phase 22 (18.2%)

Phase 33 (27.3%)

Phase 41 (9.1%)

N/A4 (36.4%)

Trials by Status

completed862%

recruiting18%

withdrawn18%

terminated215%

unknown18%

Recent Activity

1 active trials

Showing 5 of 13

completednot_applicable

Acute Maternal Hyperoxygenation for Fetal Transposition of the Great Arteries (TGA)

NCT03771534

completednot_applicable

Acute Maternal Hyperoxygenation in CHD

NCT03944837

terminatedphase_4

Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation

NCT04223050

recruitingphase_2

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

NCT05237505

completedphase_3

Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock

NCT04990349

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT03771534Not Applicable

Acute Maternal Hyperoxygenation for Fetal Transposition of the Great Arteries (TGA)

Completed

NCT03944837Not Applicable

Acute Maternal Hyperoxygenation in CHD

Completed

NCT04223050Phase 4

Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation

Terminated

NCT05237505Phase 2

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

Recruiting

NCT04990349Phase 3

Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock

Completed

NCT05922020Not Applicable

Hyperoxia on Ventilation During Recovery From General Anesthesia

Completed

NCT04554225

Pulmonary Disease Requiring Ambulatory Oxygen Therapy -Resilience and Quality of Life

Unknown

NCT04003116Phase 3

Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE)

Completed

NCT05150418Phase 1

Supplemental Oxygen in Hypovolemia

Completed

NCT03625700

Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality

Completed

NCT03369184Phase 3

Elective Percutaneous Coronary Intervention With or Without Supplemental OXYgen

Terminated

NCT04398290Phase 2

iNOPulse for COVID-19

Withdrawn

NCT02344732Not Applicable

Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy

Completed

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13